Scleromyxedema (Arndt-Gottron Syndrome): a Case Report

1. Breathnach SM. Mucinoses. In: Burns DA, Breathnach SM, Cox NH, Griffiths CEM, editors. Rook’s textbook of dermatology. 8th edition. Oxford: Blackwell Publishing Ltd; 2010. p. 59.21-59.30.Search in Google Scholar

2. Rongioletti F, Rebora A. Mucinosis. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2^nd edition. London: Mosby Elsevier; 2008. p. 611-21.Search in Google Scholar

3. Maize J, Maize J Jr, Metcalf J. Metabolic diseases of the skin. In: Elder DE, Elenitsas R, Johnson BL Jr, Murphy GF, editors. Lever’s histopathology of the skin. 9^th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 435-67.Search in Google Scholar

4. Dubreuilh W. Fibromes miliares folliculaires: sclerodermie consecutive. Arch Dermatol Syph 1906;37:569-72.Search in Google Scholar

5. Reitmann K. Uber eine eigenartige, der sklerodermie nahestehende affection. Arch Dermatol Syph 1908;92:417-24.10.1007/BF01949029Search in Google Scholar

6. Montgomery H, Underwood LJ. Lichen myxedematosus (diferentiation from cutaneous myxedemas or mucoid states). J Invest Dermatol 1953;20(3):213-36.10.1038/jid.1953.2513044990Search in Google Scholar

7. Gottron HA. Skleromyxödem; eine eigenartige Erscheinungsform von Myxothesaurodermie. Arch Klin Exp Dermatol 1954;199(1):71-91.10.1007/BF00362184Search in Google Scholar

8. Rongioletti F, Rebora AN. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001;44(2):273-81.10.1067/mjd.2001.11163011174386Search in Google Scholar

9. Azfar NA, Khan AR, Zaman T, Jahangir M. Scleromyxedema in an HCV-positive male. Journal of Pakistan Association of Dermatologists 2008;18:116-8.Search in Google Scholar

10. Savran Y, Akarsu S. Dermato-neuro syndrome in a case of scleromyxedema. Eur J Rheumatol 2015; DOI:10.5152/eurjrheum.2015.0116.10.5152/eurjrheum.2015.0116504723027708955Search in Google Scholar

11. Serdar ZA, Altunay IK, Yasar SP, Erfan GT, Gunes P. Generalized papular and sclerodermoid eruption: scleromyxedema. Indian Dermatol Venereol Leprol 2010;76(5):592.10.4103/0378-6323.6909620827020Search in Google Scholar

12. Weening RH, Pittelkow MR. Scleredema and scleromyxedema. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Leffell D, Paller A, editors. Fitzpatrick's dermatology in general medicine. 7th edition. New York: Mc Graw Hill Medical; 2008. p. 1562-6.Search in Google Scholar

13. Salas-Alanis JC, Martinez-Jaramillo B, Gomez-Flores M, Ocampo-Candiani J. Scleromyxedema, a therapeutic dilemma. Indian J Dermatol 2015;60(2):215.Search in Google Scholar

14. Shams M, Javadi MA, Bidaki R. Bilateral scleromyxedema of eyelids: a rare report in psychodermo-ophthalmology: clinical image. JSM Ophthalmol 2015;3(2):1030.Search in Google Scholar

15. Chan JC, Trendell-Smith NJ, Yeung CK. Scleromyxedema: a Cutaneous Paraneoplastic Syndrome associated with thymic carcinoma. J Clinical Oncol 2012;30(3):e27-9.10.1200/JCO.2011.38.393522162593Search in Google Scholar

16. Laimer M, Namberger K, Massone C, Koller J, Emberger M, Pleyer L, et al. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema. Acta Derm Venereol 2009;89(6):631-5.10.2340/00015555-073119997697Search in Google Scholar

17. Efthimiou P, Blanco M. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 2008;38(3):188-94.10.1016/j.semarthrit.2007.10.01518221985Search in Google Scholar

18. Meigel W. Mucinoses. In: Burgdorf WH, Plewig G, Wolf HH, Landthaler M, editors. Braun-Falco's dermatology. 3th ed. Munich: Springer; 2009. p. 1263-73.10.1007/978-3-540-29316-3_87Search in Google Scholar

19. Mehta V, Balachandran C, Rao R. Arndt Gottron scleromyxedema: successful response to treatment with steroid minipulse and methotrexate. Indian J Dermatol 2009;54(2):193-5.10.4103/0019-5154.53183280716920101325Search in Google Scholar

20. Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 2006;107(2):463–6.10.1182/blood-2004-12-4870189560516179379Search in Google Scholar

21. Péus D, Newcomb N, Hofer S. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak 2013;13:72.10.1186/1472-6947-13-72372204123870327Search in Google Scholar